147 related articles for article (PubMed ID: 26557672)
1. Analysis of Hereditary Elliptocytosis with Decreased Binding of Eosin-5-maleimide to Red Blood Cells.
Suemori S; Wada H; Nakanishi H; Tsujioka T; Sugihara T; Tohyama K
Biomed Res Int; 2015; 2015():451861. PubMed ID: 26557672
[TBL] [Abstract][Full Text] [Related]
2. Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins.
King MJ; Jepson MA; Guest A; Mushens R
Int J Lab Hematol; 2011 Apr; 33(2):205-11. PubMed ID: 21054813
[TBL] [Abstract][Full Text] [Related]
3. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders.
Tachavanich K; Tanphaichitr VS; Utto W; Viprakasit V
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):570-5. PubMed ID: 19842445
[TBL] [Abstract][Full Text] [Related]
4. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
[TBL] [Abstract][Full Text] [Related]
5. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
[TBL] [Abstract][Full Text] [Related]
7. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
[TBL] [Abstract][Full Text] [Related]
8. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
[TBL] [Abstract][Full Text] [Related]
10. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
[TBL] [Abstract][Full Text] [Related]
11. Mean corpuscular volume of control red blood cells determines the interpretation of eosin-5'-maleimide (EMA) test result in infants aged less than 6 months.
Ciepiela O; Adamowicz-Salach A; Bystrzycka W; Łukasik J; Kotuła I
Ann Hematol; 2015 Aug; 94(8):1277-83. PubMed ID: 25907377
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis.
Kar R; Mishra P; Pati HP
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):8-16. PubMed ID: 18782334
[TBL] [Abstract][Full Text] [Related]
13. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia.
King MJ; Behrens J; Rogers C; Flynn C; Greenwood D; Chambers K
Br J Haematol; 2000 Dec; 111(3):924-33. PubMed ID: 11122157
[TBL] [Abstract][Full Text] [Related]
14. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.
Christensen RD; Agarwal AM; Nussenzveig RH; Heikal N; Liew MA; Yaish HM
J Perinatol; 2015 May; 35(5):357-61. PubMed ID: 25357094
[TBL] [Abstract][Full Text] [Related]
15. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
[TBL] [Abstract][Full Text] [Related]
17. Improved harmonization of eosin-5-maleimide binding test across different instruments and age groups.
Agarwal AM; Liew MA; Nussenzveig RH; Sangle N; Heikal N; Yaish H; Christensen R
Cytometry B Clin Cytom; 2016 Nov; 90(6):512-516. PubMed ID: 26384602
[TBL] [Abstract][Full Text] [Related]
18. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.
King MJ; Smythe JS; Mushens R
Br J Haematol; 2004 Jan; 124(1):106-13. PubMed ID: 14675415
[TBL] [Abstract][Full Text] [Related]
19. Hereditary red cell membrane disorders and laboratory diagnostic testing.
King MJ; Zanella A
Int J Lab Hematol; 2013 Jun; 35(3):237-43. PubMed ID: 23480868
[TBL] [Abstract][Full Text] [Related]
20. [Flowcytometric diagnostics of hereditary spherocytosis].
Riley CH; Nikolajsen K; Kjaersgaard E; Klausen TW; Mourits-Andersen T; Clausen N; Lausen B; Rosthøj S; Birgens H
Ugeskr Laeger; 2009 Nov; 171(49):3610-4. PubMed ID: 19954702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
